Medical Condition News

RSS

Microbiome science merges with oncology for better cancer treatments

Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies.

7 Jul 2026

Study offers insight into how long-term inflammation may contribute to cognitive decline

The King's College London study, published in Nature Communications, offers insight into how long-term inflammation may contribute to cognitive decline in disorders such as Alzheimer's disease, aging, depression, and the lingering neurological effects of viral infections.

7 Jul 2026

Gut microbiome changes can signal future type 2 diabetes risk

The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who go on to develop type 2 diabetes years later.

7 Jul 2026

Beckman Coulter Diagnostics expands Alzheimer’s portfolio with CE-marked p-Tau217 blood test and new high-specificity research assay

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline.

7 Jul 2026

Study reveals long-term, intergenerational impacts of severe preconception trauma

Can the trauma of a parent rewrite the mental health of a child born decades later? A new compelling study reveals that children born decades after the Holocaust to parents who were older than age five at the time of the initial Nazi persecutions faced elevated schizophrenia risk.

7 Jul 2026

Sustainable oyster meat extract may reduce human intestinal inflammation

Ongoing research provides evidence that readily-available and sustainable oyster meat extract may have powerful anti-inflammatory effects on human intestinal cells.

7 Jul 2026

Estonian study highlights value of early genetic tests to identify hereditary cancer risks

In 2013, Angelina Jolie inspired a wave of testing for pathogenic variants of the gene BRCA1 by announcing that she carried a variant which left her at such high risk of breast cancer, she chose a preventive mastectomy.

7 Jul 2026

U.S. obesity rates rose sharply between 1999 and 2023

Obesity rates among U.S. adults and children rose sharply in recent years and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published today in the American Heart Association's flagship journal Circulation.

7 Jul 2026

Could IVF affect heart health after pregnancy?

Women with IVF-conceived pregnancies exhibit higher large artery stiffness, indicating potential cardiovascular risks that warrant further investigation.

7 Jul 2026

ADHD and autism traits share a common developmental spectrum

Research identifies a neurodevelopmental spectrum for ADHD and autism, emphasizing genetic links and their impact on cognitive and educational outcomes.

7 Jul 2026

Short sleep and poor sleep quality track with Parkinson’s risk

Using CHARLS data from 2011 to 2020, researchers found that sleep duration and self-reported sleep quality were associated with Parkinson’s disease risk in middle-aged and older Chinese adults. Short sleep was linked to higher PD risk, while age-specific patterns suggested a linear association in adults aged ≤60 years and a U-shaped relationship in those aged >60 years.

6 Jul 2026

Trial supports glargine use in resource-limited Type 1 diabetes care

A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogues in low-resource settings.

6 Jul 2026

AI uncovers hidden molecular signals linked to thrombosis risk

Two people may be the same age and have similar family histories or risk factors, yet only one of them may develop thrombosis.

6 Jul 2026

Study identifies promising drug target to prevent neurodegenerative conditions

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

6 Jul 2026

Case study shows how accurate diagnosis can guide personalized treatment for renal oncocytoma

A new case report was published in Volume 17 of Oncotarget on July 2, 2026, titled "Renal oncocytoma: Α case report and literature review."

6 Jul 2026

Study compares different light therapies for treating Alzheimer's disease

The researchers treated 5‑month‑old 5xFAD mice – a model with aggressive amyloid deposition – with 810‑nm light (25 mW/cm² at the scalp, ~6.25 mW/cm² brain dose for CW, and half that for 40‑Hz due to 50% duty cycle) for 10 minutes daily over 37 days.

6 Jul 2026

Study finds specialized gambling addiction services underused in Quebec

A new study finds public specialized gambling addiction treatment services are underused in Quebec, pointing to a need to better reach people with gambling disorder.

6 Jul 2026

Study explores the relationship between heart issues and cognitive function

New in JNeurosci, Xia Zhang, from the Max Planck Institute for Human Cognitive and Brain Sciences, led a study exploring the relationship between heart issues and cognitive function.

6 Jul 2026

Psychiatry may be moving closer to precision medicine

For decades, treating depression has largely involved a difficult form of medical guesswork: prescribing one antidepressant after another in hopes that one will eventually help.

6 Jul 2026

Researchers identify a distinct subtype of eosinophilic esophagitis in children

Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic esophagitis (EoE) – a chronic allergic inflammatory disorder in which the esophagus narrows, interfering with food going down properly.

6 Jul 2026